Another view on the analysis of cardiovascular morbidity/mortality trials

  • Gerd K. Rosenkranz
  • Pharmaceutical Statistics, April 2010, Wiley
  • DOI: 10.1002/pst.434

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1002/pst.434

The following have contributed to this page: Dr Gerd K Rosenkranz